跳至主要内容
临床试验/ACTRN12614001194651
ACTRN12614001194651已完成未知

In patients undergoing percutaneous liver biopsy, do prophylactic use of pethidine, compared to no treatment, reduce the anxiety and post procedural pain relief

Gastroenterology unit, Dunedin Hospital0 个研究点目标入组 100 人开始时间: 2014年11月13日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
16 Years 至 85 Years(—)
性别
All

入选标准

  • All patients undergo percutaneous liver biopsy at Dunedin hospital

排除标准

  • 1) Patients with previous allergic reaction to pethidine or metoclopramide; 2) Patients with clotting disorders and abnormal prothrombin time with international normalized ratio (INR) of greater than 1.5 or thrombocytopenia with platelet less than 50 x 109 per litre; 3) abdominal ultrasound revealed a contraindication to PLB such as massive ascites, intrahepatic duct dilatation, or focal lesion; 4) patients without a telephone for study follow up; and 5) patients with a solitary lesion that required target biopsy under ultrasound guidance

研究者

发起方
Gastroenterology unit, Dunedin Hospital

相似试验